Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy (PD)

June 6, 2020 updated by: Ayman El Nakeeb, Mansoura University

Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy for Periampullary Tumour (Multicenter Study)

Very few papers examine the effect of living at high altitudes on surgical results of major operations. This research is designed to determine the surgical outcomes of PD for periampullary tumour in high altitudes and normal altitudes.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Many recent studies have suggested multiple risk factors affecting postoperative surgical outcomes of PD; THE research is designed to determine the surgical outcomes of PD for periampullary tumour in high altitudes and normal altitude.

it is a multicenter study Aseer central hospital, Saudia and from Egypt two centers Mansoura university and el Menia university

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mansoura, Egypt, 356111
        • Mahmoud Abd El Wahab

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • periampulary tumour

Exclusion Criteria:

  • liver cirrhosis,
  • PG,
  • advanced tumour,
  • vascular resection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: PD in normal altitude
PD underwent in the area at the level of the sea, normal altitude region
dissection and removal of periampulary tumour with 3 reconstruction PJ, HJ, and GJ
Other Names:
  • Whippl,s operation
Active Comparator: PD in high altitude region.
PD underwent in high altitude region.
dissection and removal of periampulary tumour with 3 reconstruction PJ, HJ, and GJ
Other Names:
  • Whippl,s operation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the overall postoperative complications
Time Frame: 30 DAYS
the overall postoperative complications
30 DAYS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood loss
Time Frame: INTRAOPERATIVE
blood loss
INTRAOPERATIVE
Pulmonary embolism (PE)
Time Frame: 30 days
Pulmonary embolism (PE)
30 days
hospital mortality
Time Frame: 30 days
death within 30 days of operation
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ayman E Nakeeb, MD, Mansoura University, Gastrointestinal Surgery Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

April 1, 2020

Study Completion (Actual)

April 25, 2020

Study Registration Dates

First Submitted

May 21, 2020

First Submitted That Met QC Criteria

May 22, 2020

First Posted (Actual)

May 26, 2020

Study Record Updates

Last Update Posted (Actual)

June 9, 2020

Last Update Submitted That Met QC Criteria

June 6, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • PD in high altitude

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

it will be available for other researchers

IPD Sharing Time Frame

6 month

IPD Sharing Access Criteria

elnakeebayman@yahoo.com

IPD Sharing Supporting Information Type

  • Study Protocol

Study Data/Documents

  1. Study Protocol
    Information identifier: Ayman El Nakeeb
    Information comments: through elnakeebayman@yahoo.com

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periampullary Cancer

3
Subscribe